Direxion Daily LLY Bull 2X Shares(ELIL)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
2-STAR RATING
Consider higher Upturn Star rating
BUY for 9 days
PROFIT SINCE LAST BUY
+5.28% ▲
LAST CLOSE
$33.91
10/28/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for ELIL

10/28/2026: ELIL (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Direxion Daily LLY Bull 2X Shares (ELIL) is a leveraged ETF designed to provide 200% of the daily performance of Eli Lilly and Company (LLY). It offers active traders a convenient tool to amplify gains on LLY's price movements but carries significant risks due to daily compounding and the inherent volatility of a single-stock concentration. The fund is best suited for short-term tactical betting rather than long-term investment. Investors should carefully monitor LLY-specific catalysts and be aware that returns over periods longer than a single day are subject to volatility decay.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitThis is a tactical trading tool, not a suitable core holding for a long-term growth portfolio.
Momentum investorStrong fit while signal remains positiveMomentum traders can utilize this to amplify gains during strong uptrends in LLY stock.
Value investorWeak fitLeveraged daily products are generally contrary to the principles of long-term value investing.
Dividend/Income investorWeak fitThe fund does not provide reliable income and is prone to capital erosion through volatility decay.
Low-risk investorWeak fitThe high leverage and single-stock concentration make this inappropriate for risk-averse investors.

Investor Profile

Ideal Investor Profile

Sophisticated traders who monitor the market closely and have a high risk tolerance.

Suitability

Strictly for active, short-term traders; unsuitable for passive or long-term investors.

Risk Profile

Risk factorLevelWhy it matters
VolatilityHighDaily rebalancing and 2x leverage significantly amplify the impact of daily price swings.
Market riskHighThe fund is entirely dependent on the market performance of a single company, Eli Lilly.
ConcentrationStrongHaving 100% exposure to one stock eliminates the benefits of diversification.
Tracking/expenseMedium / highMathematical compounding leads to performance drift over periods longer than a single day.
LiquidityMediumTrading costs can be significant during periods of low volume or high market stress.
Business/sector qualityMediumPerformance is tied to the success or failure of LLY's pharmaceutical pipeline and competitive market position.

Risk Analysis

Volatility

Extreme, as the fund is designed to double the daily volatility of a single, often news-sensitive stock.

Market Risk

The fund carries significant idiosyncratic risk; it is entirely dependent on the performance of a single company, Eli Lilly.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
Single stockEli Lilly and Company (LLY) — seeks 2x daily return100The fund's performance is driven entirely by the daily price movements of Eli Lilly and Company shares magnified by a 2x factor.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Choppy
PRICE STABILITY

Choppy

The stock has experienced frequent reversals and pronounced short-term price swings.

Analysis of Past Performance

Type ETF
Historic Profit 55.99%
Avg. Invested days 35
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 4.0
ETF Returns Performance Upturn Returns Performance icon 5.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 10/28/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.